BIOLOGICAL AND CHEMICAL EVALUATION OF AMIDE-BASED CJOC42 DERIVATIVES AS POTENTIAL GANKYRIN-INHIBITORS FOR THE TREATMENT OF BREAST, LUNG, AND LIVER CANCER